BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Shipping container with flag of China

China med-tech exports declined in 2021 as imports increased

Jan. 5, 2022
By Zhang Mengying
China’s med-tech products exports declined in 2021 as manufacturing in other countries picked up, while med-tech imports to the country increased. In the first half of 2021, China’s med-tech exports amounted to $47.931 billion, a decrease of 23.1% year-on-year. But imports for the same period amounted to $24.392 billion, an increase of 25.2% year-on-year, according to med-tech data company Guangzhou Joinchain Big Data Technology Co. Ltd.
Read More
Teen receiving vaccine

ACIP on board with boosters for adolescents

Jan. 5, 2022
By Mari Serebrov
Once the CDC accepts the recommendation of its Advisory Committee on Immunization Practices (ACIP), the COVID-19 vaccine regimen, at least for the Pfizer Inc.-Biontech SE vaccine, will include a booster dose for everyone 12 and older. ACIP voted 13-1 at a Jan. 5 emergency meeting to recommend the booster dose for 12- to 17-year-olds at least five months after a primary series of the Pfizer vaccine.
Read More
COVID-19 research illustration

Biopharmas keep on keeping on, despite mounting omicron infections

Jan. 5, 2022
By Karen Carey
Just as the world appeared to be winning the battle against COVID-19, the rules of the game changed. Omicron and concerns about future variants flipped the board. Vaccines and monoclonal antibodies are attracting fresh scrutiny as SARS-CoV-2 evolves. Cases are climbing closer to the highest levels recorded since the pandemic began. Antivirals are aiming to fill treatment gaps, but whether they will or not is about as clear as the virus’ next move.
Read More

Regulatory actions for Jan. 5, 2022

Jan. 5, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Abbvie, Abionyx, Adverum, Akeso, Amylyx, Ananda, Astrazeneca, Cstone, Cullinan, Everest, Iliad, Genprex, Immix, Jazz, Knight, Melt, Nordic, Novavax, Oryzon, Pfizer, PTC, Spero, Splisense, Verseau, Viridian.
Read More

Other news to note for Jan. 5, 2022

Jan. 5, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Actinium, Alloy, Ares, Aveo, Biorchestra, Biohaven, Biontech, Champions, Covis, Cue, Cyclenium, Dotbio, Elicera, Epicentrx, Eversana, F-star, Genentech, Immunicum, Insilico, Intellia, Intravacc, Junshi, Kyverna, Lixte, LG Chem, Mannkind, Mdimune, Merck KGaA, Mindset, McQuade, Nanotic, Nikang, Novartis, Owp, PCI, Peptilogics, Pfizer, Prism, Roche, SK, Spectrum, Suono, Thirona, Twist, Vuja, Zynerba.
Read More

In the clinic for Jan. 5, 2022

Jan. 5, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve, Aldeyra, Amryt, Anebulo, Astrazeneca, Belief, Bionomics, Concert, Humanigen, Kintor, Newamsterdam, Onquality, Orano Med, Orphomed, Pieris, Proqr, Radiomedix, Stuart, Union.
Read More
U.S. Capitol building

Sens. Blunt, Burr press Becerra on HHS use of monies allocated by Congress for testing

Jan. 4, 2022
By Mark McCarty
Over the course of the past two years, two presidential administrations and the U.S. Congress have set considerable sums of money aside for testing for the COVID-19 pandemic, but reports of shortages of tests have prompted a response from Capitol Hill.
Read More
Lungs

Study shows nanoparticles could help reduce acute lung inflammation in COVID-19

Jan. 4, 2022
By Meg Bryant
Researchers at the University of Pennsylvania’s Perelman School of Medicine have shown how nanoparticles could be used to reduce neutrophil clumping in inflamed lungs – making them a pathway for diagnosis and treatment of acute lung inflammation (ALI) and acute respiratory distress syndrome (ARDS).
Read More

Other news to note for Jan. 4, 2022

Jan. 4, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advicenne, Affiris, Allarity, Amyris, Arbor, Aveo, Astrazeneca, Bayer, Biogen, Biologics of Jemincare, Biomx, Biorestorative, Cognition, Cumberland, Evotec, Frontier, Genocea, Genprex, Green Cross, Hansa, Hoth, Immunitybio, Ionis, J&J, Kyverna, Kyowa, Merck, Oncoheroes, Ovid, Prometheus, Rivaara, Santhera, Sperogenix, Soligenix, TCR2, Tonix, Vaxil.
Read More

In the clinic for Jan. 4, 2022

Jan. 4, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alentis, Alladapt, Asieris, Beigene, Celltrion, Compass, Dystrogen, Ensysce, Equillium, Gannex, Gritstone, Harbour, Mindmed, Relay, Vaccinex.
Read More
Previous 1 2 … 145 146 147 148 149 150 151 152 153 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 11, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing